Literature DB >> 11735218

Cloning, pharmacology, and tissue distribution of G-protein-coupled receptor GPR105 (KIAA0001) rodent orthologs.

K Freeman1, P Tsui, D Moore, P C Emson, L Vawter, S Naheed, P Lane, H Bawagan, N Herrity, K Murphy, H M Sarau, R S Ames, S Wilson, G P Livi, J K Chambers.   

Abstract

It has recently been shown that UDP-glucose is a potent agonist of the orphan G-protein-coupled receptor (GPCR) KIAA0001. Here we report cloning and analysis of the rat and mouse orthologs of this receptor. In accordance with GPCR nomenclature, we have renamed the cDNA clone, KIAA0001, and its orthologs GPR105 to reflect their functionality as G-protein-coupled receptors. The rat and mouse orthologs show 80% and 83% amino acid identity, respectively, to the human GPR105 protein. We demonstrate by genomic Southern blot analysis that there are no genes in the mouse or rat genomes with higher sequence similarity. Chromosomal mapping shows that the mouse and human genes are located on syntenic regions of chromosome 3. Further analyses of the rat and mouse GPR105 proteins show that they are activated by the same agonists as the human receptor, responding to UDP-glucose and closely related molecules with similar affinities. The mouse and rat receptors are widely expressed, as is the human receptor. Thus we conclude that we have identified the rat and mouse orthologs of the human gene GPR105.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735218     DOI: 10.1006/geno.2001.6662

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  19 in total

Review 1.  Signalling and pharmacological properties of the P2Y receptor.

Authors:  T K Harden; J I Sesma; I P Fricks; E R Lazarowski
Journal:  Acta Physiol (Oxf)       Date:  2010-03-24       Impact factor: 6.311

2.  GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity.

Authors:  Jianfeng Xu; Hidetaka Morinaga; Dayoung Oh; Pingping Li; Ai Chen; Saswata Talukdar; Yaël Mamane; Joseph A Mancini; Andrea R Nawrocki; Eduardo Lazarowski; Jerrold M Olefsky; Jane J Kim
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

3.  P2Y14 Receptor Antagonists Reverse Chronic Neuropathic Pain in a Mouse Model.

Authors:  Fatma Mufti; Young-Hwan Jung; Luigino Antonio Giancotti; Jinha Yu; Zhoumou Chen; Ngan B Phung; Kenneth A Jacobson; Daniela Salvemini
Journal:  ACS Med Chem Lett       Date:  2020-04-30       Impact factor: 4.345

Review 4.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

5.  Functional expression of the P2Y14 receptor in murine T-lymphocytes.

Authors:  Michelle Scrivens; John M Dickenson
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 6.  UDP-Sugars as Extracellular Signaling Molecules: Cellular and Physiologic Consequences of P2Y14 Receptor Activation.

Authors:  Eduardo R Lazarowski; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2015-03-31       Impact factor: 4.436

7.  The G protein-coupled receptor P2Y14 influences insulin release and smooth muscle function in mice.

Authors:  Jaroslawna Meister; Diana Le Duc; Albert Ricken; Ralph Burkhardt; Joachim Thiery; Helga Pfannkuche; Tobias Polte; Johannes Grosse; Torsten Schöneberg; Angela Schulz
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

8.  A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.

Authors:  Matthew O Barrett; Juliana I Sesma; Christopher B Ball; P Suresh Jayasekara; Kenneth A Jacobson; Eduardo R Lazarowski; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2013-04-16       Impact factor: 4.436

9.  Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction.

Authors:  Anna-Karin Wihlborg; Johanna Balogh; Lingwei Wang; Catharina Borna; Ying Dou; Bhalchandra V Joshi; Eduardo Lazarowski; Kenneth A Jacobson; Anders Arner; David Erlinge
Journal:  Circ Res       Date:  2006-03-16       Impact factor: 17.367

10.  Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor.

Authors:  Rhonda L Carter; Ingrid P Fricks; Matthew O Barrett; Lauren E Burianek; Yixing Zhou; Hyojin Ko; Arijit Das; Kenneth A Jacobson; Eduardo R Lazarowski; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2009-09-16       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.